Search News
Latest News
LGP signs key UK supply agreement
Little Green Pharma Ltd (ASX: LGP, “LGP” or the “Company”) is pleased to announce the entry into a medicinal cannabis distribution agreement (“Agreement”) with Sana Life Sciences Ltd (“Sana”) for...
2022 Outlook from CEO Fleta Solomon
2021 was another remarkable year for Little Green Pharma. While not without its challenges, (adjusting to a roadmap out of COVID-19 while having more than 120 employees in four countries!)...
LGP awarded Italian Government tender
Little Green Pharma is pleased to announce the award of an Italian Government tender to deliver a shipment of EU GMP medicinal cannabis flower from its Danish Facility into Italy....
Research partnership to tackle obesity epidemic with medicinal cannabis
Research partnership to tackle obesity epidemic with medicinal cannabis Little Green Pharma and Curtin University have joined forces to explore the use of medicinal cannabis treatment options for obesity and...
LGP Signs Exclusive Distribution Agreement with PharmaServe Hellas
Little Green Pharma Ltd (ASX: LGP, “LGP” or the “Company”) is pleased to announce its entry into an exclusive agreement with PharmaServe Hellas SMSACI (“PharmaServe”) for the distribution of LGP-branded oil...
LGP Signs Exclusive Oils Distribution Agreement with German Distributor AMP
Highlights: LGP signs three-year distribution agreement with AMP for the distribution of LGP-branded cannabis oil medicines in Germany AMP is a leading pharmaceutical supplier of medical cannabis products with one...
GMP: what does it mean and why is it important?
All pharmaceutical products manufactured and distributed in Australia must adhere to principles and procedures that ensure that the goods produced meet a minimum quality standard. This standard is referred to...
Little Green Pharma Marks World AIDS Day
December 1st marks the 40th observation of World AIDS Day in Australia. The day raises awareness across the world and in the community about the issues surrounding HIV and AIDS. It is...
LGP Denmark granted registration for its “Billinol LGP”
Little Green Pharma is pleased to announce it has been granted a product registration for its 16% THC “Billinol LGP” cannabis flower medicine by the Danish Medicines Agency. The grant...
Little Green Pharma supports Fibromyalgia study at SCU
LGP to provide funding for a three-year PhD Scholarship research supervision to Southern Cross University study into treatment of Fibromyalgia syndrome (FMS) using medicinal cannabis LGP to provide funding for...